Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Porgador

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1993
Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genesA Porgador, E Tzehoval, E Vadai, et al.
The Journal of Biological Chemistry|August 22, 1997
Production of a specific major histocompatibility complex class I-restricted epitope by ubiquitin-dependent degradation of modified ovalbumin in lymphocyte lysateS Ben-Shahar, B Cassouto, L Novak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attainedE J Wherry, K A Puorro, A Porgador, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1993
Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cellsA Porgador, R Bannerji, Y Watanabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivoA Porgador, H F Staats, B Faiola, et al.
International Journal of Cancer|December 15, 1994
Effective anti-metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with Newcastle disease virus (NDV)D Plaksin, A Porgador, E Vadai, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapyA Katz, L M Shulman, A Porgador, et al.
European Journal of Immunology|September 6, 2001
Recognition of viral hemagglutinins by NKp44 but not by NKp30T I Arnon, M Lev, G Katz, et al.
Current Medicinal Chemistry|March 15, 2012
The effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cellsB Rosental, M Y Appel, R Yossef, et al.
Immunity|June 1, 1997
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibodyA Porgador, J W Yewdell, Y Deng, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1993
Immunotherapy via gene therapy: comparison of the effects of tumor cells transduced with the interleukin-2, interleukin-6, or interferon-gamma genesA Porgador, E Tzehoval, E Vadai, et al.
The Journal of Biological Chemistry|August 22, 1997
Production of a specific major histocompatibility complex class I-restricted epitope by ubiquitin-dependent degradation of modified ovalbumin in lymphocyte lysateS Ben-Shahar, B Cassouto, L Novak, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 22, 1999
The induction of virus-specific CTL as a function of increasing epitope expression: responses rise steadily until excessively high levels of epitope are attainedE J Wherry, K A Puorro, A Porgador, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1993
Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cellsA Porgador, R Bannerji, Y Watanabe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 1997
Intranasal immunization with CTL epitope peptides from HIV-1 or ovalbumin and the mucosal adjuvant cholera toxin induces peptide-specific CTLs and protection against tumor development in vivoA Porgador, H F Staats, B Faiola, et al.
International Journal of Cancer|December 15, 1994
Effective anti-metastatic melanoma vaccination with tumor cells transfected with MHC genes and/or infected with Newcastle disease virus (NDV)D Plaksin, A Porgador, E Vadai, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|February 1, 1993
Abrogation of B16 melanoma metastases by long-term low-dose interleukin-6 therapyA Katz, L M Shulman, A Porgador, et al.
European Journal of Immunology|September 6, 2001
Recognition of viral hemagglutinins by NKp44 but not by NKp30T I Arnon, M Lev, G Katz, et al.
Current Medicinal Chemistry|March 15, 2012
The effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cellsB Rosental, M Y Appel, R Yossef, et al.
Immunity|June 1, 1997
Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibodyA Porgador, J W Yewdell, Y Deng, et al.
Pageof 3